First Tracks Biotherapeutics (TRAX) — Defensive Interval Ratio
First Tracks Biotherapeutics (TRAX) has a Defensive Interval Ratio of 0 days as of June 2026. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $34.10K/day. Explore TRAX long-term investments to assets to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
First Tracks Biotherapeutics Defensive Interval Ratio (2023–2025)
This chart shows how First Tracks Biotherapeutics's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. Read First Tracks Biotherapeutics (TRAX) financial obligations for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for First Tracks Biotherapeutics (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for First Tracks Biotherapeutics from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see First Tracks Biotherapeutics asset portfolio.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 864 days | $73.44 Million | $84.99K/day | $- | $73.44 Million | ▼ -1782 days |
| 2024 | 2646 days | $262.29 Million | $99.13K/day | $- | $262.29 Million | ▼ -4463 days |
| 2023 | 7109 days | $354.94 Million | $49.93K/day | $- | $354.94 Million | — |